Page last updated: 2024-08-22

pyrvinium and dasatinib

pyrvinium has been researched along with dasatinib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ang, SH; Asari, K; Bunte, RM; Cheong, JK; Chuah, C; Sun, WT; Teo, B; Than, H; Virshup, DM; Xiang, W; Xu, P1

Other Studies

1 other study(ies) available for pyrvinium and dasatinib

ArticleYear
Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration.
    Oncotarget, 2015, Oct-20, Volume: 6, Issue:32

    Topics: Adenosine Triphosphate; Animals; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; beta Catenin; Blast Crisis; Casein Kinase I; Cell Line, Tumor; Cell Proliferation; Dasatinib; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, SCID; Mitochondria; Neoplasm Transplantation; Phosphorylation; Pyrvinium Compounds; RNA Interference

2015